High-potency sucralfate prevents and rapidly reverses chemo-radiation mucositis in a patient with stage 4b head and neck cancer

High-potency sucralfate prevents and rapidly reverses chemo-radiation mucositis in a patient with stage 4b head and neck cancer

• Publication year

  2013

• Venue

  Unknown venue

• Publication date

  2013-08-12

• Fields of study

  Medicine

• Identifiers
  DOI 10.5528/WJTM.V2.I2.13
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Cryotherapy and keratinocyte growth factor may be beneficial in preventing oral mucositis in patients with cancer, and sucralfate is effective in reducing its severity.

  2013cited by this paper
• Radiation dose-volume effects in radiation-induced rectal injury.

  2010cited by this paper
• Post-Infectious Irritable Bowel Syndrome, an Inflammation-Immunological Model with Relevance for Other IBS and Functional Dyspepsia

  2010cited by this paper
• Radiation Induced Oral Mucositis

  2009cited by this paper
• Palifermin (recombinant keratinocyte growth factor-1): a pleiotropic growth factor with multiple biological activities in preventing chemotherapy- and radiotherapy-induced mucositis.

  2007cited by this paper
• Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer

  2006cited by this paper
• Immunosurveillance and Immunoregulation by γδ T Cells

  2006cited by this paper
• Human intestinal αβ IEL clones in celiac disease show reduced IL-10 synthesis and enhanced IL-2 production

  2006cited by this paper
• Epithelial cells and their neighbors. III. Interactions between intraepithelial lymphocytes and neighboring epithelial cells.

  2005cited by this paper
• Nerves, reflexes, and the enteric nervous system: pathogenesis of the irritable bowel syndrome.

  2005cited by this paper
• Cytokine Production by Intestinal Intraepithelial Lymphocyte Subsets in Celiac Disease

  2005cited by this paper
• Clinical practice guidelines for the prevention and treatment of cancer therapy–induced oral and gastrointestinal mucositis

  2004cited by this paper
• The pathobiology of mucositis.

  2004cited by this paper
• Polyanions and the Proteome*

  2004cited by this paper
• Gastrointestinal pain in functional bowel disorders: sensory neurons as novel drug targets

  2004cited by this paper
• Elevated Vasoactive Intestinal Peptide Concentrations in Patients with Irritable Bowel Syndrome

  2004cited by this paper
• Intestinal Intraepithelial Lymphocyte γδ-T Cell-Derived Keratinocyte Growth Factor Modulates Epithelial Growth in the Mouse1

  2004cited by this paper
• Inflammation as a basis for functional GI disorders.

  2004cited by this paper
• The burdens of cancer therapy

  2003cited by this paper
• Abnormal levels of neuropeptide Y and peptide YY in the colon in irritable bowel syndrome

  2003cited by this paper
• The patient's perspective

  2003cited by this paper
• A role for inflammation in irritable bowel syndrome?

  2002cited by this paper
• Activation of the mucosal immune system in irritable bowel syndrome.

  2002cited by this paper
• Complications of Radiation Therapy for Head and Neck Cancers: The Patient’s Perspective

  2002cited by this paper
• Defining Clinically Meaningful Outcomes in the Evaluation of New Treatments for Oral Mucositis: Oral Mucositis Patient Provider Advisory Board

  2002cited by this paper
• Protection of the intestinal mucosa by intraepithelial γδ T cells

  2002cited by this paper
• Complex effects of molecular chaperones on the aggregation and refolding of fibroblast growth factor-1.

  2001cited by this paper
• Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation.

  2001cited by this paper
• Surveillance of the gastrointestinal mucosa by sensory neurons.

  2001cited by this paper
• Increased mast cells in the irritable bowel syndrome

  2000cited by this paper
• Visceral pain—peripheral sensitisation

  2000cited by this paper
• Mast Cell-Nerve Interactions.

  2000cited by this paper
• Intestinal lymphoepithelial communication.

  1999cited by this paper
• Immune-epithelial interactions in host defense.

  1999cited by this paper
• Gastrointestinal mucosal regeneration: role of growth factors.

  1999cited by this paper
• Clinical and pharmacokinetic risk factors for high-dose methotrexate-induced toxicity in children with acute lymphoblastic leukemia--a logistic regression analysis.

  1998cited by this paper
• The role of epidermal growth factor (EGF) and its receptor in mucosal protection, adaptation to injury, and ulcer healing: involvement of EGF-R signal transduction pathways.

  1998cited by this paper
• III. Ontogeny and function of γδ T cells in the intestine.

  1998cited by this paper
• Healing the epithelium: Solving the problem from two sides

  1997cited by this paper
• gamma/delta and other unconventional T lymphocytes: what do they see and what do they do?

  1996cited by this paper
• Inflammatory mediators of pain.

  1995cited by this paper
• Differences in intraepithelial lymphocyte T cell subsets isolated from murine small versus large intestine.

  1995cited by this paper
• Accelerated healing of duodenal ulcers by oral administration of a mutein of basic fibroblast growth factor in rats.

  1994cited by this paper
• Mast cells synthesize, store, and release nerve growth factor.

  1994cited by this paper
• Intestinal epithelial function: The case for immunophysiological regulation

  1993cited by this paper
• Intestinal epithelial function: The case for immunophysiological regulation

  1993cited by this paper
• Peptide YY stimulates circular muscle contractions of the isolated perfused canine ileum by inhibiting nitric oxide release and enhancing acetylcholine release.

  1993cited by this paper
• Sucralfate and soluble sucrose octasulfate bind and stabilize acidic fibroblast growth factor.

  1993cited by this paper
• Terminal ileal mucosal mast cells in irritable bowel syndrome

  1993cited by this paper
• Antiinflammatory effects of polypeptide growth factors. Platelet-derived growth factor, epidermal growth factor, and fibroblast growth factor inhibit the cytokine-induced expression of the alternative complement pathway activator factor B in human fibroblasts.

  1990cited by this paper
• Protective effect of sucralfate against alcohol-induced gastric mucosal injury in the rat. Macroscopic, histologic, ultrastructural, and functional time sequence analysis.

  1985cited by this paper
• A method for estimating the probability of adverse drug reactions

  1981cited by this paper
• WHO Handbook for Reporting Results of Cancer Treatment

  1980cited by this paper
• Mast cells in inflammatory conditions of the gastrointestinal tract.

  1962cited by this paper

• Outsized Treatment Effects of High Potency Polymerized Cross-Linked Sucralfate (ProThelial) for Oral and Gastrointestinal Chemoradiation Mucositis The Level of Evidence and Implication for National Cancer Center Network Category 2A Recommendations

  2018cites this paper
• Complete prevention and rapid sustained elimination of chemoradiation toxic mucositis, a case series with implications for mucositis pathobiology, cost of care, morbidity and premature cancer deaths

  2017cites this paper
• Actual duration of patient-reported mucositis: Far longer than 2 to 4 weeks and may be avoidable altogether

  2016cites this paper
• A 66 patient multi-institution phase IV post-authorization surveillance of ProThelialTM (high potency polymerized cross-linked sucralfate) - single agent efficacy for the prevention and rapid reversal of chemo-radiation induced oral, esophageal and intestinal mucositis.

  2015cites this paper
• ProThelial™ (Polymerized Cross-Linked High Potency Sucralfate): Medical Device Therapy for Treatment and Prevention of Mucositis

  2014cites this paper
• Unprecedented Simultaneous and Rapid Reversal of Oral and Alimentary Mucositis using Polymerized Cross Linked Sucralfate: Two Case Reports

  2014cites this paper